Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Meta-Analyses on Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Triple-Negative Breast Cancer
Breast Cancer Res Treat 2020 Apr 03;[EPub Ahead of Print], T Hirai, A Nemoto, Y Ito, M MatsuuraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.